BSTE Biosite (MM)

FULLERTON, Calif., March 25 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE:BEC) announced today it will host a series of Communication Events for investors and analysts to review the company's proposed acquisition of Biosite, Inc. (NASDAQ:BSTE), announced earlier today. These events include: (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) Investor Webcast Beckman Coulter will host a webcast on Monday, March 26, 2007, at 8:30 am ET to discuss the transaction. The audio portion of the event may be accessed by dialing (877) 516-3365 or (706) 679-3246 and asking for the Beckman Coulter conference call or reservation #3687656. To participate via the website and obtain access to the presentation materials, please go to Beckman Coulter's website at http://www.beckmancoulter.com/ and select "go to IR" under Investor Relations and find the call listed under "What's Ahead". The webcast will be archived for future on-demand replay. Group Meetings A series of five small group meetings for institutional investors will be hosted by Scott Garrett, President and Chief Executive Officer of Beckman Coulter. Other attendees will include Charlie Slacik, Beckman Coulter's Chief Financial Officer, Ken Buechler, President and Chief Scientific Officer of Biosite, and Chris Hibberd Biosite's Senior Vice President, Corporate Development. Members of the investment community who wish to attend one of the following events should RSVP directly to Investor Relations at (714) 773-7620 or to obtain meeting details. Tuesday, March 27 - New York: Group Breakfast and Group Lunch Wednesday, March 28 - Boston: Group Lunch Thursday, March 29 - Chicago: Group Breakfast Thursday, March 29 - Minneapolis: Group Dinner About Beckman Coulter Beckman Coulter, Inc., based in Fullerton, California, develops, manufactures and markets products that simplify automate, and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world supplying critical information for improving patient health and reducing the cost of care. Recurring revenues consisting of supplies, test kits, service and operating-type lease payments represent more than 75 percent of the company's 2006 annual sales of $2.5 billion. For more information, visit http://www.beckmancoulter.com/. Contact: Robert Raynor Director, Investor Relations (714) 773-7620 http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGODATASOURCE: Beckman Coulter, Inc. CONTACT: Robert Raynor, Director, Investor Relations, +1-714-773-7620 Web site: http://www.beckmancoulter.com/

Copyright